Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System

yf_tkr_SNY · 2026-10-19 · Bullish AI sentiment

$SNY

Sanofi's CirCLIQ® Injector, developed using enFuse technology, has been approved to administer Sarclisa subcutaneous formulation, in combination with approved standard-of-care regimens, for patients with multiple myelomaCINCINNATI, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a leader in wearable drug delivery technologies, today announced the first regulatory approval of its enFuse® On-Body Delivery System technology by Japan’s Ministry of Health, Labour and Welfare thr

Sector coverage: Healthcare · Drug Manufacturers - General

Read the original at yf_tkr_SNY ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.